EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation

Amer Elias iD, Shani Stern iD

Cells · 2026

DOI: 10.3390/cells15080720 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Amer Elias und 1 weiteren Autor:innen. Beteiligte Einrichtung: Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel. Hauptthemen laut MEDLINE: Gene Editing, Nervous System Diseases, Mental Disorders, Genetic Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurological and mental disorders are among the main causes of disability worldwide, affecting over three billion people and increasing the socioeconomic burden. Advances in molecular genetics and genome engineering have led to gene-targeted therapies that address root causes rather than just symptoms. This review covers current genome-editing tools, including CRISPR/Cas, base editing, and prime editing. The focus is on the benefits of gene editing in the central nervous system, where post-mitotic neurons allow lasting effects after a single treatment. It also discusses emerging delivery platforms such as viral vectors, nanoparticles, and exosome systems, as well as methods to bypass the blood–brain barrier. Recent clinical progress in spinal muscular atrophy, Parkinson’s disease, Huntington’s disease, and Alzheimer’s disease is highlighted, with promising preclinical results for autism, bipolar disorder, epilepsy, and other neurogenetic conditions. The review concludes with regulatory issues, market trends, and ongoing clinical trials, underscoring the potential of gene therapies to transform disease management and provide long-term solutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingNervous System DiseasesMental DisordersGenetic TherapyTranslational Research, BiomedicalGene Transfer TechniquesHumansAnimalsCRISPR-Cas SystemsBlood-Brain Barrier

Stichwörter der Autor:innen

Adeno-Associated Virus (AAV)Blood–Brain Barrier (BBB)CRISPR-CasCentral Nervous System (CNS)base editingexosomesgene editingneurological disordersprecision medicineprime editing

Autor:innen und Institutionen

  • Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel.

ORCID-Profile: Amer Elias, Shani Stern

Zitieren

APA

Elias, A., & Stern, S. (2026). Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation. Cells. https://doi.org/10.3390/cells15080720

Vancouver

Elias A, Stern S. Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation. Cells. 2026. doi:10.3390/cells15080720

BibTeX
@article{Elias2026,
  author = {Elias, Amer and Stern, Shani},
  title = {Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15080720}
}
Kostenlos starten →